Feb 22, 2011 ... Syllabus. BRUESEWITZ ET AL. v. WYETH LLC, FKA WYETH, INC.,. ET AL. CERTIORARI TO THE UNITED STATES COURT OF APPEALS FOR.
Oct 12, 2010 ... Oral Argument: Oct. 12, 2010 Appealed From: United States Court of Appeals for the Third Circuit (Mar. 8, 2010)
10 U.S.C. 1408, as interpreted in Mansell v. Mansell,. 490 U.S. 581 (1989). ..... et seq. (U.S. Navy and U.S. Marine Corps); 10 U.S.C.. 8911 et seq. (U.S. Air ...
Rowe BH, Bota G, Clark S, et al. Comparison of Canadian versus American emergency department visits for acute asthma. Can Respir J. 2007;14:331–7.
Swenson et al. determined the vancomycin susceptibility of 129 S. aureus isolates ... Merck, Nabriva, Novartis, Pfizer (Wyeth), Rempex, Rib-X Pharmaceuticals, ... Clinical features of heteroresistant vancomycin-intermediate Staphylococcus aureus bacteremia versus those of .... Bland CM, Porr WH, Davis KA, Mansell KB.
Jul 22, 2010 ... Richard M. Bergenstal, M.D., William V. Tamborlane, M.D., Andrew Ahmann, M.D. , John B. Buse, M.D., Ph.D., George Dailey, M.D., Stephen N.
v. GENE W. ZDENEK et al., Defendants and Respondents. No. B213416. Court of Appeals of California, Second District, Division Two. Filed January 5, 2011.
CEE (0.625 mg versus placebo). 0.77 (0.59–1.01). Observational .... et al.19 with early-stage breast. LNG-IUS before could be due to a longer cancer exposed to.
May 30, 2009 ... Ziprasidone vs clozapine in schizophrenia patients refractory to multiple .... clozapine and ziprasidone from this study (Harvey et al., 2008). 2. Methods. 2.1. ...... Italfarmaco, Janssen-Cilag, Lundbeck, Pfizer, Sanofi-Aventis, and Wyeth. Lederle; he is .... Chuang, H.T., Mansell, C., Patten, S.B., 2008. Lifestyle ...